|
Parallel Imported Pharmaceutical and Healthcare Products
The parallel import (PI) scheme allows medicinal products authorised in other European countries to be marketed in the UK in competition with the identical product supplied by the original manufacturer.
Ginova UK Limited:
- imports pharmaceutical and healthcare products from over 10 European countries into the UK.
- repackages against an increasing product portfolio of over 200 Parallel Import licences and Distribution Notifications.
- works closely with and contract packs for other UK parallel importers.
- repackages refrigerated / low temperature products.
- repackages controlled drugs up to schedule 2 (Home Office Licence Number 055469).
- holds an MHRA Wholesale Dealers Licence (WL25973).
- holds an MHRA Manufacturers (Assembly) Licence (MIA25973).
The granting of parallel import (PI) licences in the EU for such a purpose began in 1984. The MHRA liaises closely with the relevant competent authorities to obtain the necessary information to ensure that only those products which fully comply with the stringent criteria for parallel import are granted a licence.
Alternatively, Parallel Distribution is the distribution of a centrally authorised medicinal product from one Member State to another by a pharmaceutical company independent of the marketing-authorisation holder. The EMEA checks the compliance of products distributed in parallel with the conditions laid down in Community legislation on medicinal products and in the marketing authorisation of the product.
|
